A complete blood count (CBC) test is then conducted to determine if the platelet count is below normal
The current review aimed to provide a literature review of the current published reports on the association, the possible mechanisms, and the related individualized risk factors that might lead to this incidence
23 Another approach using nonviral gene delivery of plasmids encoding PBGD in human and mouse PBGD-deficient fibroblasts resulted in a high expression of functional PBGD
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
doi: 10.3389/fphar.2024.1515172 Received 22 October 2024 Accepted 20 December 2024 Published 07 January 2025 Volume 15 - 2024 Edited by Di Yang, Fudan University, China Reviewed by Monika E
